Jong Wook Kim

University of California San Diego

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index13

i10-index14

Publications42

Citations2,467

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last latest available · showing 20 of 21

Supplementary Materials and Methods from A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway InhibitorsPreprint
2023-04-03
Supplemental Figure Legends from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> MutationsPreprint
2023-04-03
Supplemental Tables 1-16 from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> MutationsPreprint
2023-04-03
Supplemental Figure Legends from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> MutationsPreprint
2023-04-03
Supplemental Tables 1-16 from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> MutationsPreprint
2023-04-03
Supplementary Figures S1-S19 from A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway InhibitorsPreprint
2023-04-03
Supplementary Materials and Methods from A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway InhibitorsPreprint
2023-04-03
Supplementary Figures S1-S19 from A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway InhibitorsPreprint
2023-04-03
Supplementary Figure 1 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsPreprint
2023-03-31
Supplementary Table 1 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic Targets
2023-03-31
Supplementary Figure 3 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsPreprint
2023-03-31
Supplementary Table 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic Targets
2023-03-31
Supplementary Figure 3 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsPreprint
2023-03-31
Supplementary Table 1 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic Targets
2023-03-31
Supplementary Figure 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsPreprint
2023-03-31
Supplementary Figure 1 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsPreprint
2023-03-31
Supplementary Table 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic Targets
2023-03-31
Supplementary Figure 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsPreprint
2023-03-31
Targeting TBK1 to overcome resistance to cancer immunotherapy
Nature · 2023-01-12 · 167 citations
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells
eLife · 2020-01-08 · 61 citations

Open author page on OpenAlex →